Valo Health Acquires Courier Therapeutics

Valo Health Acquires TARA Biosystems

April 5, 2022

Biotechnology

Valo Health has acquired TARA Biosystems, a New York City–based company specializing in human 3D tissue engineering and cardiac disease modeling, to create an integrated cardiovascular drug discovery and development platform. The deal combines TARA's in vitro cardiac models with Valo's Opal computational platform to expand Valo's capabilities in cardiovascular drug discovery and accelerate development of new therapies.

Valerio Therapeutics Acquires Emglev Therapeutics

September 29, 2024

Biotechnology

Valerio Therapeutics S.A. completed the acquisition of Emglev Therapeutics on September 29, 2024, transferring Emglev's proprietary synthetic single-domain antibody (sdAb) platform into a newly formed Valerio subsidiary, Valour Bio. The deal was structured as a cash sale of shares combined with a contribution-in-kind (Emglev shares exchanged for Valour Bio shares), making Emglev shareholders shareholders of Valour Bio and positioning Valour Bio to advance sdAb discovery and development across oncology and inflammatory/autoimmune indications.

Associated Couriers Acquires Specialty Freight & Courier

November 1, 2020

Logistics & Distribution

Associated Couriers, LLC (St. Louis) has acquired Specialty Freight & Courier, a Florida-based medical and final-mile courier with offices in Jacksonville and Tampa. The acquisition — effective November 2020 and announced February 1, 2021 — expands Associated Couriers' regional same-day, last-mile and next-day capabilities in Florida and the Southeastern U.S., increasing the buyer's national footprint to 40 states.

Curative Inc. Acquires KorvaLabs, Inc.

May 19, 2020

Healthcare Services

Curative Inc. has acquired KorvaLabs, a CLIA-certified and DEA-licensed analytical laboratory based in San Dimas, California, formalizing a partnership that supported Curative's manufacture and processing of its oral fluid COVID-19 test. The acquisition strengthens Curative's testing capacity — to date the organizations processed 245,371 tests together and were processing roughly 14,000 tests per day — and secures in-house manufacturing and processing capabilities.

Merck & Co., Inc. Acquires VelosBio Inc.

November 5, 2020

Biotechnology

Merck & Co., Inc. will acquire all outstanding shares of clinical-stage biopharmaceutical company VelosBio for $2.75 billion in cash. The acquisition adds VelosBio's lead investigational antibody-drug conjugate VLS-101 and ROR1-directed pipeline assets to Merck's oncology portfolio and is expected to close by the end of 2020, subject to customary conditions.

Valsoft Corporation Acquires Datatrac Corporation

April 5, 2023

Transportation

Montreal-based Valsoft Corporation has acquired Datatrac Corporation, a 40+-year provider of cloud-based last-mile courier software based in Metro Atlanta. Datatrac will join Valsoft's Transportation & Logistics portfolio (operating alongside Aspire Software) as an add-on to expand Valsoft's logistics technology capabilities and customer offerings.